Skip to main content

Tweets

SKIPPAIN Trial: Dr. Sheila Reyes ( @RHEUMarampa) reviews abstract #0899 presented at #ACR20. https://t.co/yoQ8MEH2Br https://t.co/1uRKEp88le
Dr. John Cush RheumNow( View Tweet)
6 minutes 6 seconds ago
#BestACR20Tweets RT @ejdein1 : Worth checking out the #ACR20 image competition. Here's an image of cerebral toxoplasmosis during ADA treatment for RA https://t.co/JH07pMjvRe https://t.co/H9LHwiw4xL
Dr. John Cush RheumNow( View Tweet)
36 minutes 5 seconds ago
Auckland-based rheumatologist Dr. Nicola Dalbeth discusses improving responses to the use of Pegloticase, including abstracts #0677 and #0952 presented at #ACR20. https://t.co/xeiMYLZEQa https://t.co/a4RJ6BrNgn
Dr. John Cush RheumNow( View Tweet)
1 hour 51 minutes ago
Vaccination with Shingrix: Does it work for patients on JAKi? #ACR20 https://t.co/PLWn3SshcI https://t.co/APBcfP1zlH
Dr. John Cush RheumNow( View Tweet)
2 hours 36 minutes ago
Nomenclature, Uveitis and Other Spondyloarthritis Features with Dr. Lianne Gensler #ACR20 https://t.co/zql7iySXOA https://t.co/PY9k108QTc
Dr. John Cush RheumNow( View Tweet)
3 hours 51 minutes ago
#BestACR20Tweets RT @doctorRBC : Tocilizumab NOT effective in preventing mechanical ventilation or death in moderately ill COVID-19 pts. Double-blind, Placebo, RCT (n=243) @RheumNow #ACR20 Abs#L07 #ACRbest https://t.co/Gi5FpodeKf https://t.co/bTk8n7dNni
Dr. John Cush RheumNow( View Tweet)
5 hours 35 minutes ago
Warfarin and Risk of Hip and Knee Replacements with Dr. Mrinalini Dey ( @DrMiniDey) #ACR20. https://t.co/znTxIx1QQZ https://t.co/elQlChwr0N
Dr. John Cush RheumNow( View Tweet)
6 hours 36 minutes ago
#BestACR20Tweets RT @KDAO2011 : The FAST trial had 33% of pts with CVD and pts w/class III/IV CHF weren't allowed in this study; still cautious prescribing febuxostat to pts who have severe CVD until we have more data. https://t.co/eyl2kOjEEU https://t.co/qoQDgRifFg
Dr. John Cush RheumNow( View Tweet)
7 hours 48 minutes ago
Let us know your thoughts on our article titled "Undifferentiated Autoinflammatory Syndrome Called VEXAS" https://t.co/afNK3UuZef #ACR20 https://t.co/fp2sX9w894
Dr. John Cush RheumNow( View Tweet)
9 hours 5 minutes ago
#BestACR20Tweets RT @synovialjoints : Can we find Axial Spa (FaxSpa) using social media? This study used an online screening tool (A-tool) on social media in patients with back pain. 42% had a positive screen and referred for review @RheumNow #ACR20 Abstr#1894

Dr. John Cush RheumNow( View Tweet)

9 hours 51 minutes ago
Dr. Kathryn Dao ( @KDAO2011) reviews abstract #0533 presented at #ACR20 on male osteoporosis. https://t.co/Z0NLcJzslV https://t.co/SSoIA7Eetg
Dr. John Cush RheumNow( View Tweet)
21 hours 6 minutes ago
#BestACR20Tweets RT @DrMiniDey : Late breaking: in older #rheumatoidarthritis patients, those taking MTX have 2x risk of #VTE compared to those on HCQ. Important to consider #thromboembolic risk factors when starting new RA treatment. Abs#2000 #ACR20 https://t.co/lMYlXgaHyE https://t.co/0Fdone9yb3
Dr. John Cush RheumNow( View Tweet)
23 hours 6 minutes ago
×